Eli Total Assets from 2010 to 2025

LLY Stock

USD 844.27 26.09 3.00%

Eli Lilly Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1985-12-31

Previous Quarter

71.9 B

Current Value

75.6 B

Quarterly Volatility

15.3 B

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as Depreciation And Amortization of 965 M, Interest Expense of 635.7 M or Total Revenue of 47.3 B, as well as many indicators such as Price To Sales Ratio of 16.28, Dividend Yield of 0.0085 or PTB Ratio of 51.19. Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.

Check out the analysis of Eli Lilly Correlation against competitors.

Latest Eli Lilly's Total Assets Growth Pattern

Below is the plot of the Total Assets of Eli Lilly and over the last few years. Total assets refers to the total amount of Eli Lilly assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Eli Lilly books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Eli Lilly's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eli Lilly's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 64.01 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Eli Total Assets Regression Statistics

	Arithmetic Mean	44,176,228,266
	Geometric Mean	38,797,229,617
	Coefficient Of Variation	39.17
	Mean Deviation	11,947,181,799
	Median	43,908,400,000
	Standard Deviation	17,304,644,040
	Sample Variance	299450705.4T
	Range	73.3B
	R-Value	0.89
	Mean Square Error	64261755.4T
	R-Squared	0.80
	Slope	3,250,382,785
	Total Sum of Squares	4491760580.5T

Eli Total Assets History

	2025	77.3 B
	2024	73.6 B
	2023	64 B
	2022	49.5 B
	2021	48.8 B
	2020	46.6 B
	2019	39.3 B

Other Fundumenentals of Eli Lilly

Intangibles To Total Assets

Eli Lilly Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Accounts Payable	Short Term Investments	Capital Stock	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital
Total Assets		0.17	0.89	0.04	0.96	-0.12	0.09	0.78	0.82	0.97	-0.34	-0.77	-0.77	0.9	0.56	0.85	0.65	0.85	-0.48	0.64	0.79	-0.16	0.84	-0.44	0.58	-0.7
Total Stockholder Equity	0.17		-0.18	0.95	0.01	-0.16	0.08	-0.11	0.11	0.11	0.68	0.38	0.38	-0.25	-0.07	0.35	0.01	-0.01	0.67	-0.44	-0.23	0.67	0.01	0.17	0.35	0.06
Net Debt	0.89	-0.18		-0.34	0.96	-0.15	-0.08	0.86	0.82	0.94	-0.59	-0.94	-0.94	0.95	0.51	0.67	0.71	0.94	-0.68	0.78	0.84	-0.43	0.87	-0.69	0.59	-0.88
Retained Earnings	0.04	0.95	-0.34		-0.16	-0.04	0.18	-0.2	-0.05	-0.04	0.79	0.55	0.55	-0.37	-0.03	0.23	-0.07	-0.2	0.7	-0.54	-0.37	0.78	-0.15	0.35	0.11	0.26
Net Receivables	0.96	0.01	0.96	-0.16		-0.16	0.0	0.81	0.84	0.98	-0.51	-0.87	-0.87	0.94	0.48	0.78	0.64	0.92	-0.56	0.72	0.83	-0.32	0.88	-0.57	0.65	-0.8
Total Liab	-0.12	-0.16	-0.15	-0.04	-0.16		0.93	0.07	-0.38	-0.2	-0.03	0.12	0.12	-0.02	0.26	0.15	0.19	-0.19	-0.29	0.24	0.1	0.03	-0.35	0.04	-0.34	0.24
Total Current Assets	0.09	0.08	-0.08	0.18	0.0	0.93		0.08	-0.2	-0.03	0.07	0.12	0.12	0.06	0.29	0.35	0.24	-0.11	-0.19	0.23	0.16	0.16	-0.17	0.15	-0.16	0.21
Intangible Assets	0.78	-0.11	0.86	-0.2	0.81	0.07	0.08		0.52	0.82	-0.45	-0.81	-0.81	0.86	0.53	0.68	0.78	0.85	-0.71	0.76	0.76	-0.22	0.57	-0.73	0.36	-0.74
Short Term Debt	0.82	0.11	0.82	-0.05	0.84	-0.38	-0.2	0.52		0.86	-0.28	-0.64	-0.64	0.7	0.29	0.56	0.5	0.79	-0.25	0.39	0.55	-0.15	0.97	-0.41	0.74	-0.79
Accounts Payable	0.97	0.11	0.94	-0.04	0.98	-0.2	-0.03	0.82	0.86		-0.4	-0.81	-0.81	0.9	0.5	0.79	0.67	0.93	-0.49	0.64	0.77	-0.22	0.89	-0.58	0.66	-0.82
Short Term Investments	-0.34	0.68	-0.59	0.79	-0.51	-0.03	0.07	-0.45	-0.28	-0.4		0.77	0.77	-0.66	-0.26	-0.21	-0.27	-0.44	0.75	-0.75	-0.69	0.88	-0.34	0.46	-0.18	0.4
Capital Stock	-0.77	0.38	-0.94	0.55	-0.87	0.12	0.12	-0.81	-0.64	-0.81	0.77		1.0	-0.94	-0.48	-0.59	-0.63	-0.85	0.82	-0.88	-0.91	0.66	-0.71	0.68	-0.45	0.75
Common Stock	-0.77	0.38	-0.94	0.55	-0.87	0.12	0.12	-0.81	-0.64	-0.81	0.77	1.0		-0.94	-0.48	-0.59	-0.63	-0.85	0.82	-0.88	-0.91	0.66	-0.71	0.68	-0.45	0.75
Long Term Debt	0.9	-0.25	0.95	-0.37	0.94	-0.02	0.06	0.86	0.7	0.9	-0.66	-0.94	-0.94		0.6	0.72	0.7	0.85	-0.79	0.88	0.92	-0.49	0.78	-0.56	0.46	-0.71
Treasury Stock	0.56	-0.07	0.51	-0.03	0.48	0.26	0.29	0.53	0.29	0.5	-0.26	-0.48	-0.48	0.6		0.56	0.62	0.42	-0.54	0.57	0.59	-0.21	0.36	-0.17	0.11	-0.25
Property Plant Equipment	0.85	0.35	0.67	0.23	0.78	0.15	0.35	0.68	0.56	0.79	-0.21	-0.59	-0.59	0.72	0.56		0.74	0.68	-0.4	0.66	0.8	-0.04	0.58	-0.4	0.59	-0.5
Good Will	0.65	0.01	0.71	-0.07	0.64	0.19	0.24	0.78	0.5	0.67	-0.27	-0.63	-0.63	0.7	0.62	0.74		0.69	-0.61	0.73	0.74	-0.18	0.58	-0.54	0.51	-0.61
Current Deferred Revenue	0.85	-0.01	0.94	-0.2	0.92	-0.19	-0.11	0.85	0.79	0.93	-0.44	-0.85	-0.85	0.85	0.42	0.68	0.69		-0.51	0.66	0.73	-0.27	0.82	-0.75	0.66	-0.92
Net Tangible Assets	-0.48	0.67	-0.68	0.7	-0.56	-0.29	-0.19	-0.71	-0.25	-0.49	0.75	0.82	0.82	-0.79	-0.54	-0.4	-0.61	-0.51		-0.92	-0.82	0.67	-0.37	0.48	-0.01	0.42
Long Term Debt Total	0.64	-0.44	0.78	-0.54	0.72	0.24	0.23	0.76	0.39	0.64	-0.75	-0.88	-0.88	0.88	0.57	0.66	0.73	0.66	-0.92		0.95	-0.61	0.5	-0.54	0.33	-0.51
Capital Surpluse	0.79	-0.23	0.84	-0.37	0.83	0.1	0.16	0.76	0.55	0.77	-0.69	-0.91	-0.91	0.92	0.59	0.8	0.74	0.73	-0.82	0.95		-0.58	0.63	-0.54	0.46	-0.58
Long Term Investments	-0.16	0.67	-0.43	0.78	-0.32	0.03	0.16	-0.22	-0.15	-0.22	0.88	0.66	0.66	-0.49	-0.21	-0.04	-0.18	-0.27	0.67	-0.61	-0.58		-0.24	0.34	-0.06	0.26
Short Long Term Debt	0.84	0.01	0.87	-0.15	0.88	-0.35	-0.17	0.57	0.97	0.89	-0.34	-0.71	-0.71	0.78	0.36	0.58	0.58	0.82	-0.37	0.5	0.63	-0.24		-0.42	0.73	-0.81
Cash And Equivalents	-0.44	0.17	-0.69	0.35	-0.57	0.04	0.15	-0.73	-0.41	-0.58	0.46	0.68	0.68	-0.56	-0.17	-0.4	-0.54	-0.75	0.48	-0.54	-0.54	0.34	-0.42		-0.46	0.85
Net Invested Capital	0.58	0.35	0.59	0.11	0.65	-0.34	-0.16	0.36	0.74	0.66	-0.18	-0.45	-0.45	0.46	0.11	0.59	0.51	0.66	-0.01	0.33	0.46	-0.06	0.73	-0.46		-0.67
Net Working Capital	-0.7	0.06	-0.88	0.26	-0.8	0.24	0.21	-0.74	-0.79	-0.82	0.4	0.75	0.75	-0.71	-0.25	-0.5	-0.61	-0.92	0.42	-0.51	-0.58	0.26	-0.81	0.85	-0.67

Click cells to compare fundamentals

About Eli Lilly Financial Statements

Eli Lilly investors use historical fundamental indicators, such as Eli Lilly's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Eli Lilly. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	73.6 B	77.3 B
Intangibles To Total Assets	0.17	0.11

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC